RAC Regulatory Affairs Certification Exam

An adverse event that is listed in the current product labeling, but is now occurring with greater severity. A serious adverse event that is already well-documented in the Investigator's Brochure from the clinical trial phase. A non-serious adverse event observed for the first time in a postmarketing study. A mild headache, which is listed as a common side effect in the product's core safety information.